SafeBeat

SafeBeat Rx, founded by a multidisciplinary team of physicians, engineers, data scientists, and machine learning experts, aims to revolutionize cardiac care management. The company's core mission is to enhance access to remote patient monitoring and therapeutic guidance through mobile-powered ML ECG software. SafeBeat Rx offers solutions that integrate with FDA-cleared wearables, enabling seamless physician approval of drug dosing and continuous ECG monitoring directly from a mobile phone. Their market focus includes individuals with heart rhythm disorders requiring rigorous ECG monitoring for medication management.

Notable affiliations include a diverse team of clinicians and technologists dedicated to improving cardiac therapeutics. Key investors and partnerships have bolstered the company's innovative approach, though specific names are not disclosed. SafeBeat Rx has achieved significant milestones in remote patient monitoring (RPM), remote therapeutic monitoring (RTM), and cardiac implantable electronic device monitoring. The overall impact of SafeBeat Rx lies in its ability to provide life-saving cardiac care management remotely, making critical healthcare more accessible and efficient.